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                                                    INTRODUCTION 
      Acute kidney injury is not a single disease but a terminology for a 
group of conditions that have similar diagnostic features, importantly, an 
elevation in the blood urea nitrogen (BUN) level and / or an elevation in the 
plasma or serum creatinine (S.Cr) concentration, often associated with a 
decrease in urine volume. 
             AKI can vary in severity from asymptomatic and transient changes in 
laboratory measures of glomerular filtration rate (GFR), to exaggerated and 
rapidly fatal derangements in effective circulating blood volume, electrolyte 
and acid-base composition of the plasma. 
              AKI is the cause for 5–7% of acute care hospital admissions and 
30% of intensive care admissions. The epidemiology of AKI varies 
enormously between developed and developing regions, because of 
differences in demographics, social and cultural factors. But recent change in 
cultural habits, life style changes and social values in developing regions 
produce the near similar picture as developed countries. 
 
The incidence of AKI has increased by more than fourfold in the United 
States from 1988 and is calculated to have a yearly incidence of 500 per 
100,000 persons, more than the yearly incidence of cerebrovascular 
accidents. AKI causes a markedly increased risk of death in hospitalized 
persons, especially in those admitted to the ICU where in patient death rates 
may be more than 50%. 
The term acute renal failure was changed to "acute kidney injury." The 
term failure denotes only portion of the spectrum of damage to the kidney 
that occurs clinically. Also the term renal is not well understood in the 
general population and this makes understanding with patients and their 
caretakers more difficult; so the term renal failure has been changed to acute 
kidney injury. 
Western literature has lot of data regarding the occurrence and nature 
of acute kidney injury both in the community and inpatient setting. Sadly we 
are lagging behind in this regard as there are not many records or reports on 
this topic .This prompted me to take up this study which would throw light 
on the present scenario of acute kidney injury in intensive care unit. I 
sincerely believe in the relevance of this topic in our set up and hence chose 
this topic as my dissertation. 
 
 
 
                      REVIEW OF LITERATURE 
Kidney is the major organ involved in our body homeostasis. It maintains 
equilibrium between intracellular and extracellular compartments. It also 
protects against various insults occurring to the body which can be 
exogenous or endogenous. The kidneys functions can be excretory, synthetic, 
absorptive and it can operate as a paracrine or endocrine organ secreting 
hormones. 
RENAL PHYSIOLOGY: 
      Nephron is the functional unit of the kidney. This functional unit is grossly 
divided into glomerulus and tubules. The glomerulus consists of afferent 
arterioles, efferent arterioles, tuft of capillaries, and Bowman‘s capsule. 
Podocytes covering the capillary endothelium play a significant role in forming 
the filtration barrier. Tubules can be divided into proximal convoluted tubule, 
distal convoluted tubule, loop of Henle and collecting duct. 
           The blood flowing through the glomerulus gets filtered into the renal 
tubules as a plasma like fluid. As the filtered fluid passes further downward 
glomerulus, most of which gets absorbed. Only 1.2 litres of urine is excreted 
per day with nitrogenous waste products and acids arising from metabolism. 
Various regulatory processes have been involved in this mechanism. 
REGULATORY PROCESSES:  
AUTOREGULATION: 
Even though the mean arterial pressure of our body can vary from 90mm to 
180 mm hg, the glomerular filtration is remarkably and reasonably kept at a 
constant rate by a process called ― auto regulation ―. 
When there is reduced renal perfusion the afferent arteriole dilates and efferent 
arteriole constricts thereby increasing the filtration fraction and preserving the 
renal function. Prostacyclin is involved in afferent arteriole dilatation and 
angiotensin II in efferent arteriole constriction. 
The myogenic reflex1 is a defence mechanism against variations in glomerular 
blood flow. Acute changes in renal perfusion pressure causes reflex 
constriction or dilatation of the afferent arteriole in order to increase or 
decrease pressure. This mechanism helps to protect the glomerular capillary 
pressure from abrupt changes in mean arterial pressure. 
 
 
  
This picture shows the glomerulus, and the podocytes which 
engulf the capillaries to form the filtration barrier. 
TUBULO GLOMERULAR FEEDBACK 
Whenever there is increased tubular flow, thereby indirectly indicating an 
increased delivery of sodium and chloride, the macula densa, which is present 
in the distal tubule senses the increased load and sends a signal which has been 
found to be probably adenosine, thus constricting the afferent arterioles and 
reducing the glomerular filtration. 
 
GLOMERULOTUBULAR BALANCE: 
Whenever there is increased glomerular filtration there will be an 
increased absorption of solutes along with an increased absorption of water. 
Indirectly this means the efferent arteriole, and the subsequently emerging 
peritubular capillaries carry less water and have a high oncotic pressure .This 
reflects in the interstitium too and following the Starling‘s forces, there is 
increased reabsorption of solutes and water from the tubules thereby 
maintaining constancy. 
RENIN ANGIOTENSIN SYSTEM: 
Whenever there is decreased sodium delivery to the distal tubules, the 
macula densa causes secretion of renin from the Juxta Glomerular cells via an 
ATP mediated mechanism. The renin converts angiotensinogen to angiotensin 
I which is converted to angiotensin II by ACE. This angiotensin II causes 
sodium retention by aldosterone mediated pathway. 
  
WATER REABSORBTION 
Antidiuretic hormone (ADH) plays an important role in producing 
concentrated or diluted urine by inserting aquaporin 2 channels in the luminal 
side of the collecting duct. The receptor for ADH action is the V2 receptor 
family. Whenever there is a dysregulation in this mechanism hyponatremia 
may occur due to the relative increase in the water content. 
ACID BASE BALANCE: 
Most of the hydrogen ions get secreted in the proximal convoluted tubule via 
Na+H+ antiport mechanism. Carbonic anhydrase mediates the production of H+ 
ions in the renal tubular cells .The secreted H+ ions are buffered by ammonium 
and diphosphate ions to maintain the ph of the tubular fluid. This is called 
urinary titrable acidity. H+ ions also get secreted in the distal tubule by 
aldosterone mediated pathway. 
POTASSIUM REGULATION: 
Most of the potassium gets absorbed in the proximal convoluted bule. 
Potassium is also secreted in the collecting tubules by aldosterone mediated 
pathway. 
 
COUNTERCURRENT MECHANISM 
The Loop of Henle acts as a counter current multiplier which makes the 
medullary interstitium more hyper tonic compared to the cortex and the tubular 
lumen. This enables the production of more concentrated urine. The vasa recta 
acts as a counter current exchanger which also helps in making the medullary 
interstitium hypertonic by retaining urea and other solutes in the interstitium. 
 
 
ACUTE KIDNEY INJURY PATHOPHYSIOLOGY: 
 
The glomerulus and the tubules can get injured due to various causes. 
The glomerular filtration barrier is more susceptible to immune mediated 
injury which causes disruption of the barrier resulting in proteinuria and 
hematuria. It also gets affected by chronic diseases like diabetes and 
hypertension and diseases affecting renal vascular system like atherosclerosis 
and vasculitis. 
Tubules get affected by ischemia particularly the S 3 segment 3 of the 
proximal convoluted tubule and thick ascending limb of the loop of Henle. The 
renal medulla is also more prone to ischemia due to vascular arrangement. The 
renal tubules are also affected by endogenous and exogenous toxins which 
cause direct injury to the tubular epithelium.  
  
Any obstruction in the urinary outflow builds up a back pressure which 
increases the hydrostatic pressure in the Bowman‘s capsule resulting in 
decreased glomerular filtration. 
By definition acute kidney injury is characterized by an abrupt decline of 
renal function which leads to an accumulation of nitrogenous waste products. It 
can be symptomless with subtle changes in the levels of urea; creatinine or it 
can be rapidly fatal. 
APPROACH TO ACUTE KIDNEY INJURY: 
First step is to identify 
    the elevation in the blood urea nitrogen and creatinine 
    any reduction in the urine output 
    any alteration in the acid base changes 
    accumulation of uremic toxins 
Next is to find out whether it is reversible, either partially or fully with 
the aid of the clinical scenario. 
A meticulous history regarding the fluid intake, drug intake, associated 
comorbid factors, associated infections and previous illnesses is crucial. 
Look for anaemia, jaundice, rashes, patency of peripheral vessels and 
hydration status. 
Identify the patients who need emergency intervention like renal 
replacement therapy which can be intermittent or continuous. 
Identify the patients who are at risk of further progression. 
CATEGORISATION 
Categorise the patient into either pre-renal, intrinsic renal or post renal 
pathology. 
Identify the site of the lesion whether it is in the glomerulus or tubules by urine 
microscopy. 
 
 
 
PRE RENAL AZOTEMIA 
Prerenal azotemia can occur in the following clinical scenario. 
When there is reduced effective circulatory volume due to 
 
 Dehydration 
 Decreased stroke volume due to cardiac diseases 
 Peripheral vaso dilation due to liver cell failure 
 Sepsis 
      When there is defective renal auto regulation by 
 ACE inhibitors 
 COX inhibitors 
 Cyclosporine 
 
INTRINSIC AKI 
Any event causing direct injury to the glomerulus, tubules, 
interstitium or renal vasculature leading to compromised renal function can 
cause this type of AKI. Causes include the following. 
Glomerulonephritis by 
i)       immune mechanism 
ii)      viral infections(HBV, HCV, HIV) 
iii) others(malaria, leprosy, leptospirosis, rickettsial infection) 
iv) endocarditis 
v)        vasculitis 
vi) storage disorders 
Diseases affecting tubules-interstitium 
i)       ischemia 
ii)       sepsis 
iii) exogenous toxins(drugs, contrast) 
iv) endogenous toxins(hemolysis, rhabdomyolysis) 
 
 
 POST RENAL 
 urethral obstruction 
 Retro peritoneal fibrosis 
 Bladder outlet obstruction 
CLINICAL EVALUATION: 
A patient with acute kidney injury may be oliguric or non oliguric. In oliguric 
AKI reduced urine output occurs before the elevation of creatinine, so monitoring 
the urine output will identify the AKI much earlier than the creatinine 
measurement. 
In non oliguric AKI, we have to rely on urea, creatinine measurements to 
guide us. It takes around 24 hours for urea and creatinine to rise after GFR has 
reduced. Recent biomarkers may be helpful in early detection of AKI. 
 
PITFALLS IN CREATININE AS A MARKER OF AKI4 
 It varies with the muscle mass. 
 In a wasted patient the creatinine may be 
inappropriately low. On the other hand in a muscular 
patient it may be spuriously high. 
 Certain drugs can interfere with creatinine secretion. Eg. trimethoprim, cimetidine. 
 Creatinine measurement by Jaffe‘s assay which is more 
commonly used may detect other chromogens as 
creatinine and show false elevation. 
 In a non-steady state like AKI, creatinine cannot be used in GFR measuring 
formulas. 
GFR MEASURING FORMULAS 
CockGroft-Gault Formula: 
GFR=( 140-Age)*lean body weight/Serum creatinine *72 
Multiplied by 0.85 in females 
Modified MDRD formula: 
GFR, in mL per minute per 1.73 m2 = 186.3 × (serum Cr-1.154) 
× (age-0.203) × (0.742 if female)× (1.21 if black). 
  
In case of AKI due to fluctuations in creatinine levels above said formulas 
will not be helpful. In these situations creatinine clearance serves as a better 
marker of GFR. 
Creatinine clearance= urine creatinine x urine volume /serum creatinine 
In order to avoid delay in diagnosis and assess the severity, a criteria5 has 
been formed in 2004, by the Acute Dialysis Quality Initiative workgroup. 
This is a multilevel classification system for acute kidney injury (AKI) 
identified by the acronym RIFLE. It is based on creatinine and urine output. 
It is easily applicable in clinical setting. 
RIFLE criteria has been validated by various studies in predicting the 
mortality of patients with AKI. Still further studies are going on. Some studies 
fail to show the utility of RIFLE criteria in assessing the severity of AKI, but 
most of the studies confirmed the significance of RIFLE criteria in AKI. 
 
 
 
 
 
 
 
       If a patient presents with increased urea and creatinine it may be due to 
acute kidney injury or pre- existing chronic kidney disease. Although it is 
difficult to differentiate the two conclusively at the initial presentation, certain 
variables may prove helpful. 
      
      In a patient with CKD and a GFR of less than 30 ml /min there is usually 
normocytic normochromic anaemia4. If a patient with GFR less than 30 
ml/minand he is not anaemic it suggests recent onset of kidney injury. 
  On the other hand acute kidney injury can occur with anaemia in conditions 
like haemolytic uremic syndrome, thrombotic thrombocytopenic purpura. Thus 
it is understood that such approximations cannot be taken as a rule and 
decisions regarding diagnosis and management need to be individualised. 
Another parameter of help is the kidney size. A kidney size of less than 
10cm i.e a shrunken, fibrosed kidney with loss of cortico-medullary 
differentiation denotes chronic kidney disease. 
Last but not the least meticulous history and previous records play a 
significant role in determining the disease onset. 
     CYSTATIN C 
It is used as a marker of acute kidney injury. It can detect  decrease in renal 
     function earlier than creatinine elevation. It is not affected by the factors which  
     interfere with the creatinine measurement. These are equivalent to cardiac troponins. 
     
    RECENT BIOMARKERS: 21, 22 
 β2 microglobulin 
 Kidney injury molecule(KIM) 
 Neutrophil gelatinase associated lipocalin 
 Interleukin- 18 
 Feteuin A. 
       AKI has been classified into 
 Prerenal, 
 Intrinsic 
 Postrenal. 
      
 
 
 
 
 PRERENAL AKI 
         It is due to impaired renal perfusion by the local causes and systemic causes. 
Pathologically no injury or necrosis occurs to the renal tissue. 
The main criteria to define the pre renal AKI is the return of urea, creatinine     
values to the baseline within 72 hours of correction of the hypoperfused state. The 
following variables will be of help in identifying the prerenal AKI.4 
 Input-output chart 
 Drug history like diuretic, NSAIDS 
 Volume assessment by skin turgor, JVP. 
 History of vomiting, diarrhoea, fever, burns. 
 Any cardiac failure, shock, sepsis, chronic liver disease. 
 Urine microscopy will be normal. No abnormal cast seen. Urine 
osmolality > 500 m Osm. 
 Spot urine sodium less than 20 mEq. 
 FeNa < 1 
 BUN/Creatinine > 20 
In a hypoperfused state the tubular absorption of sodium will be more, so the 
sodium excretion will be less in the urine. But associated diuretic usage will 
increases the sodium excretion by their inherent action. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
                  TABLE 1. URINE ANALYSIS IN AKI 
 
 
 
Diagnosis 
 
Urinalysis 
Urine-to- 
Plasma 
Osmolality 
 
U Na 
(mEq/L) 
Fractional 
Excretion 
of Na 
Prerenal Normal >1.0 <20 <1.0 
Acute tubular 
necrosis 
Granular casts, 
epithelial cells 
≤1.0 >20 >1.0 
Interstitial 
nephritis 
RBCs, WBCs, ± 
eosinophils, 
granular casts 
≤1.0 >20 >1.0 
Glomerulonephritis RBCs, RBC 
casts, marked 
proteinuria 
>1.0 <20 <1.0 
Vascular disorders Normal or 
RBCs, 
proteinuria 
>1.0 <20 <1.0 
Postrenal Normal or 
RBCs, casts, 
pyuria 
<1.0 >20 >1.0 
  
 
To overcome this problem Fractional excretion of sodium (FeNa) 
will be helpful. It is not affected by diuretic usage.19 
FeNa =Urine sodium x plasma Creatinine x100/Plasma sodium x 
urine creatinine. 
In case of reduced renal perfusion there will be more tubular 
absorption of urea in relation to the creatinine so the urea level will be 
disproportinately more than the creatinine levels. So the BUN:Creatinine 
ratio will be high. 
In contrast, the BUN/Cr ratio may be decreased in decompensated 
liver failure, malnutrition, and rhabdomyolysis. In these conditions, low 
BUN/Cr ratio will occur as a result of a relative reduction in urea 
production, an increase in Creatinine production, or both. 
POST RENAL AKI  
Commonly occurs in old age.  
Usually associated with 
 Prostatic hypertrophy, 
 Pelvic malignancy, 
 Prostatic carcinoma 
 Renal stone. 
 
PREDISPOSING FACTORS: 
 Diabetes mellitus 
 Sickle cell anaemia 
 Analgesic nephropathy 
 Hypercalciuria. 
Patient may have anuria or polyuria, urinary hesitancy, urgency, colicky 
abdominal pain. 
Urine analysis will show RBCs with absent protein. In case of 
infection urine may be positive for pus cells and WBCs. USG might show 
hydronephrosis which it can occur in pregnancy as well as a normal 
phenomenon. 
 In retroperitonial fibrosis and early stages of other post renal 
diseases there will be no dilatation. CT abdomen and cystoscopy and 
retrograde pyelography will find out the level of lesion. 
INTRINSIC RENAL AKI: 
The pathology may be in the glomerulus, tubules, renal vasculature 
or interstitial tissue. Urinalysis forms the corner stone1,23 in the 
evaluation of AKI and should be performed by the nephrologist. 
Abnormal urinary sediment strongly denotes an intrarenal cause for 
renal failure. Gross color changes in the urine may be seen with various 
intrinsic renal diseases. 
 
For example, the urine of a patient with ATN usuallyappears “dirty” 
brown and opaque on gross examination due to the tubular casts. 
Reddish-brown urine or “Coca-Cola” urine1 is diagnostic of some 
patients with acute glomerulonephritis and of those with pigment-
induced tubular necrosis, including myoglobinuria . 
 In glomerulonephritis granular cast, WBC cast, RBC cast can be seen. 
 In acute tubular necrosis muddy brown granular cast can be seen. 
 In interstitial nephritis WBC cast and eosinophiluria will be present. 
 Crystalluria is usually seen in uric acid nephropathy, drug induced 
AKI and ethylene glycol intoxication. 
Next to the urine analysis renal biopsy play a significant role in 
undiagnosed glomerular disorders, ATN, interstitial nephritis. When 
clinical, biochemical, and imaging studies are not adequate to arrive at a 
conclusion, a renal biopsy should be considered. Some studies show that 
biopsy in the setting of AKI often has unexpected findings.[24] Inspite of 
that renal biopsy is considered the ―gold standard‖ for diagnostic 
accuracy in AKI. 
 
 
 
 
 
 
 GLOMERULAR DISEASE: 
Mostly it is immune mediated. Linear immune deposits along the 
glomerular basement membrane are seen in Good pastures disease. 
Granular immune complex deposition is seen in postinfectious 
glomerulonephritis, lupus nephritis, infective endocarditis, IgA 
nephropathy, Henoch Scholein purpura, membranoproliferative 
glomerulonephritis. 
Certain glomerular diseases do not have any immune complex 
deposition. Eg.Wegeners granulomatosis, Churg strauss, and microscopic 
polyangitis which are called as pauci immune glomerulonephritis. 
ACUTE TUBULAR NECROSIS 
Ischemia or toxin mediated direct damage results in acute tubular necrosis. 
ISCHEMIC ATN 
Ischemic injury to the renal tubules can occur due to the prolonged 
hypoperfusion which causes significant damage to the tubular epithelium. 
Normally the medullary interstitium is relatively hypoxic due to its 
vascular arrangements. 
The S3 segment of the proximal convoluted tubule and the thick 
ascending limb are more prone for the ischemic injury. 
Causes: 
 
 Shock 
 Haemorrhage 
 
TOXIC ATN: 
 Trauma 
 Gram negative sepsis 
 Pancreatitis 
 It can be due to any exogenous or endogenous substance. Exogenous 
causes are predominantly drugs and contrast media. 
Drugs: 
 Acyclovir, 
 Amphotericin, 
 Aminoglycoside, 
 Fluorinated anaesthetic agents, 
 Platinum compounds. 
 
 
 
Aminoglycosides cause acute tubular necrosis. They get significantly 
concentrated in renal cortex .AKI develops five to seven days after the 
therapy and it may persist even after the discontinuation of the drug. 
 
Amphotericin B causes increase in the tubulo-glomerular feedback, which 
promotes intense renal vasoconstriction. It is mainly dose and duration 
dependent. It is directly toxic to the tubules and also causes injury by the 
free radicals. 
Acyclovir gets precipitated in the renal tubules and causes crystalluria and 
also causes direct tubular toxicity. 
CONTRAST NEPHROPATHY: 
Contrast agents which are predominantly iodinated can cause this type of 
renal injury. Rise in creatinine occurs after 48 hours, peaks around 5days 
and resolves after one week. Severe renal injury requiring dialysis is rare. 
Injury occurs mainly due to hypoxia in the medullary region , cyto toxic 
injury to the tubules, and tubule obstruction by the contrast media. 
  
 
ENDOGENOUS TOXINS: 
In case of rhabdomyolysis release of myoglobulins cause injury to the 
tubules. The causes of muscle injury include crush injury, compression 
fractures, excessive exercise, heat stroke, hypothyroidism, snake bite. 
In case of hemolysis release of heme and globulins injure the tubular 
epithelium. In multiple myeloma, the light chains injure the tubules. 
If the uric acid level is more than 15 mg/dl uric acid gets precipitated in 
the tubules and results in tubular dysfunction. 
The basic problem is due to intra renal vasoconstriction, direct toxicity, 
precipitation of molecules in the tubules. These solutes get precipitated in 
the tubules along with the Tamm Horsfall protein. 
 
INTERSTITIAL NEPHRITIS: 
Many drugs can produce an idiosyncratic reaction as an allergic response 
and injure the glomerular interstitium. It also can present acutely. The 
drugs commonly causing this include methicillin, rifampicin, sulfadrugs, 
nsaids. 
Pathogenesis: 
Lymphocytic and eosinophilic infiltration of the renal interstitium and 
edema of the interstitium.6 
Certain infections may cause the same including bacteria like 
staphylococcus, streptococcus, mycobacteria and viruses like 
cytomegalovirus, Ebstein Barr virus. 
Systemic non infectious diseases like systemic lupus erythematosis may 
also cause such a disease via immune mediated reaction. 
  
 
VESSEL WALL DISORDERS: 
Athero embolic AKI: 
Patient may present with progressive renal failure in post angiography, 
post thrombolysis, post cardiac surgery. 
Atherosclerotic plaques detach from the vessel wall and occlude the distal 
renal vessels. Urine analysis may show eosinophiluria, or may be bland. 
Extrarenal features include skin necrosis, livedo reticularis. Investigations 
reveal hypocomplementemia especially a low C 3 level. 
Thrombotic micro angiopathies: 
Endothelial injury causes activation of coagulation cascade and 
formation of platelet thrombi in small vessels leading on to haemolysis, 
anaemia, thrombocytopenia along with AKI. 
Patient may have associated retinal haemorrhages, papilledema, CNS 
manifestations, malignant hypertension. 
Two diseases with this same pathologic basis are haemolytic uremic 
syndrome and thrombotic thrombocytopenic purpura. 
 
ACUTE KIDNEY INJURY IN SPECIAL SETTINGS: 
 
AKI in sepsis: 
The hemodynamic role of sepsis 1 is evident from the diffuse arterial 
vasodilatation, caused by cytokines which increase the expression of 
inducible NO synthase in the vasculature. This causes a decrease 
The underlying mechanisms are 
 Exaggerated efferent arteriole vasodilatation- especially early in the 
course of sepsis, 
 Renal vasoconstriction from activation of the sympathetic nervous 
system, 
 The renin-angiotensin-aldosterone system, 
 Vasopressin, endothelin mediated. 
Sepsis may lead to endothelial injury, which causes small vessel 
thrombosis, activation of reactive free radicals, and leukocyte adhesion 
and migration, all of which may damage renal tubular cells. 
Though the idea of sepsis has been always associated with infection, there 
is an entity called systemic inflammatory response syndrome which is 
basically a dysregulated cytokine response and uncontrolled activation of 
inflammatory mediators which itself can cause significant renal morbidity. 
The various processes contributing to kidney injury in sepsis are as 
follows7,8,9 
 Hypotension 
 Inflammatory injury to the tubules 
 Altered surface molecules in endothelium 
 Activation of rennin angiotensin system 
 Increased nitric oxide production 
 Occlusion of the small vessels by the thrombus 
Hypotension is not a prerequisite factor for development of AKI in sepsis. 
ACUTE KIDNEY INJURY AFTER SURGERY 
Several factors may play a role in causing AKI in the immediate post-
surgical period. 
The fluorinated agents used in anaesthesia sometimes produce 
nephrotoxic molecules which injure the renal tubules. 
Post-operative and intraoperative fluid imbalance may cause prerenal 
azotemia. 
Systemic inflammatory response syndrome occurs as a complication of 
surgery also produces renal shutdown. 
Patients who undergo cardiopulmonary bypass surgery are more prone to 
the development of AKI because the non-pulsatile blood circulation and 
prolonged blood flow through the extra vascular circuits cause the 
activation of the inflammatory cascade and endothelial injury10 Several 
risk stratification scoring systems for AKI after cardiac surgery, vascular 
surgery, general surgery, contrast-induced nephropathy, trauma have been 
developed . 
Acute Physiology and Chronic Health Evaluation (APACHE) I or II 
score, though not specifically made for renal dysfunction, it is a helpful 
measure of severity of any illness and also a predictor of mortality. 
 
 
 The Cleveland Clinic Foundation (CCF) score is a preoperative10 AKI  
risk score containing 
The major risk factors are in postoperative AKI include 
 
 Age more than 65 
 Gender 
 Uncontrolled hyperglycemia 
 Refractory cardiac failure 
 Chronic renal failure 
 Surgeries which are done as emergency procedures. 
 
PULMONARY RENAL SYNDROMES: 
This term denotes the presence of lung involvement in a patient with renal 
failure in the form of hemoptysis. The common causes are 
 Goodpasture‘s syndrome 
 Wegener‘s granulomatosis 
 Lupus nephritis 
Some conditions mimic this entity called as ‗pseudo‘ pulmonary renal 
syndrome. These are: 
 Buerger‘s disease with upper respiratory infections. 
 Lower respiratory tract infection associated with post 
streptococcal glomerulo nephritis. 
 Legionella infection with muscle injury. 
 
 
 
 
 
 
 
 
 
 
 
 CARDIORENAL SYNDROMES 12 
This is a far more common and worrisome problem than many kidney 
diseases in the cardiac ICU, that the nephrologist has to tackle 
DEFINITION: 
It is basically an altered hemodynamic state of cardiac and renal function 
in which acute or chronic problem in one organ will produce acute or 
chronic dysfunction in other organ. It has been classified into five types 
Type 1: acute cardiorenal syndrome: 
 sudden dysfunction of heart causing acute renal injury. 
Type 2: chronic cardiorenal syndrome : 
 chronic dysfunction of heart causing acute kidney injury.  
Type 3: acute reno cardiac syndrome : 
 acute kidney injury causing acute heart failure. 
 
Type 4: chronic renal cardiac syndrome: 
 chronic renal failure leads to heart failure and cardiac 
remodulation. 
Type5: secondary cardiorenal syndrome: 
 systemic diseases results in both heart failure and kidney injury. 
Pathopysiology underlying these syndromes include 
 Hypoperfusion of the kidney due to low stroke volume 
 Up-regulation of renin angiotensin system causing sodium and water 
accumulation. 
 Inappropriate tubulo glomerular feedback. 
 Secondary hyperaldosteronism 
 Increased afterload to the heart. 
 activation of the adrenergic system. 
Treatment includes diuretics at increased dosage, ACE 
inhibitors, conivapten, tolvapten, paracentesis, 
peritoneal dialysis, extracorporeal ultrafiltration. 
 
           HEPATORENAL SYNDROME: 
 
It is defined as a functional renal disease in patients with decompensated 
liver disease patients and portal hypertension. There is no structural damage to the 
glomerulus, tubules, or the interstitium. 
There are two types. 
Type 1 HRS: 
Doubling of serum creatinine more than 2.5 mgs% or reduction in 
creatinine clearance <20 ml /min. It usually happens after an inciting event like 
infection. It has a grave prognosis. Death occurs within two weeks. 
Type 2 HRS: 
Less severe disease, patient life can be prolonged for six months. Rate of 
rise in serum creatinine less than the type one. It usually follows intractable 
diuretic resistant ascites. 
Pathogenesis: 
Dilatation of vessels in the splanchnic circulation caused by dilatory 
molecules released in the circulation. This decreases the peripheral resistance in 
the circulation and results in arterial under filling of glomerular capillaries. 
As a compensation the renin angio tensin system gets activated leading to 
retention of sodium. The increased activation of the adrenergic system and 
endogenous vasoconstrictors produce intense glomerular vasoconstriction 
resulting in a reduced GFR. 
  
 
DIAGNOSTIC CRITERIA: 
In 1996 the international ascites club13 had made a consensus and formed a criteria 
to diagnose HRS which included major and additional criteria. This has been 
revised recently to avert some confusions. 
 Chronic liver disease with ascites 
 Plasma creatinine above 1.5mg/dl 
 No evidence of other cause of renal failure 
 No evidence for continuous fluid loss 
 Absence of shock 
 No regression in renal failure after withholding diuretics for 2 days 
and infusion of albumin. Each one of the points above should be 
present to diagnose the hepatorenal syndrome. 
Pseudo hepato renal syndrome: 
Some systemic infections or conditions affect the liver and the kidney separately 
mimicking hepato renal syndrome. The causes are 
 Sepsis, leptospirosis, tuberculosis, brucellosis 
 Hepatitis B, C, HIV, liver abscess. 
 
 SLE, vasculitis, sjogren syndrome, sacoidosis. 
Treatment of hepato renal syndrome: 
Treatment includes avoidance of diuretics, albumin infusion, vasopressors of the 
splanchnic circulation like terlipressin, vasopressin, midodrine and 
norepinephrine.14,15 Octreotide can also be used. 
In refractory cases intermittent hemodialysis can be used. All these are merely 
bridging measures to sustain life. The orthotopic liver transplantation is the 
definitive treatment. 
 
 
 
 
 
 
  
 
COMPLICATIONS OF AKI: 
Uremia : 
Accumulation of nitrogen products in our body and uremic toxins causing cellular 
dysfunction and altered mental status. 
Volume over load: 
Patient may present with weight gain, dependent edema. Resolution of kidney 
injury maybe associated with increased urine output and volume depletion which 
is due to osmotic diuresis and incomplete recovery of tubular function. 
Hyponatremia: 
Iatrogenic administration of hypotonic solutions and decreased tubular sodium 
absorption and also decreased water excretion. 
Metabolic acidosis: 
Retention of organic and other acids and consumption of bicarbonate results in 
acidosis. 
Hyperphosphatemia: 
AKI is basically a catabolic state; Also seen in muscle injury; RBC destruction too 
results in increased phosphate levels. 
Infections : 
Many infections may result in AKI and vice versa an immuno compromised state 
resulting from renal failure makes the patient more prone for infections. 
Cardiac problems: 
 Pericarditis 
 Arrhythmias 
 Pericardial effusion  
 
 
 
 
 
 
 
 
 
 
 
 
 
TREATMENT :   
PRERENAL : 
As it is a reversible state diagnosing the cause of under perfusion and correction of 
the cause is the primary treatment. It may be difficult to assess the volume status in 
AKI patient. 
Fluid challenge of one litre over 1 hour will elevate the central venous pressure. If 
the elevation is more than 5cm there may be underlying cardiac failure. So cautious 
fluid replacement is necessary4 
The central venous pressure cannot accurately reflect the volume status in left 
ventricular dysfunction. Pulmonary artery wedge pressure plays a main role in 
assessing the LV diastolic over load. 
In cardiac failure digoxin along with diuretics will relieve the congestion. In liver 
disease intravenous albumin and vasopressors might be helpful. 
INTRINSIC AKI: 
 Avoidance of offending drugs, 
 Adequate hydration in pigment induced nephropathies. 
 Treating any infection appropriately , promptly and adequately 
 Immunosuppressive drugs, steroids, plasmaphresis have been found to be   
            useful. 
 
Interventions: 
 
Slow continous ultra filtration, continuous veno venous ultrafiltration, continuous 
venovenous hemodialysis, continuous veno venous dia filtration are the continuous 
renal replacement therapies. 
Each one has its own merits and demerits. 
Intermittent versus continous hemo dialysis: 
Various studies are going on comparing the efficacy of both the modalities and 
assessing the superiority of one over other. Till now both have been proved to be 
equal in efficacy, provided they are used in appropriate clinical settings.18 
 
 
 
Peritoneal hemodialysis: 
Unlike the developed countries where the proportion of patients on peritoneal 
dialysis is far less than those on hemodialysis, the reasons for which are the subject 
matter of various studies, it is still widely prescribed to kidney disease patients in 
developing countries like India, especially in hemodynamically unstable patients. It 
has been found to have equal if not less efficacy to continuous renal replacement 
therapy. 
POST RENAL: 
Relieving the obstruction by Foleys or by any other means is the foremost thing in 
the treatment. 
EPIDEMIOLOGY OF AKI: 16 
A. Community-acquired AKI. 
The initial presentation itself is one of AKI in one percent of cases. Around 50 
% of the AKI cases occur in patients with CKD. The most common causes of 
community-acquired AKI are follows; 
 Prerenal azotemia (70%). 
 postrenal (17%). 
The death rate in community-acquired AKI is 15%. 
B. Hospital-acquired AKI.17 
The occurence of AKI in admitted patients is common. Using the RIFLE 
criteria, up to 20% of hospitalized patients may develop AKI. 
The most common causes of AKI in hospitalized patients include ischemia, sepsis, 
medications, and radiocontrast dye. 
Prerenal azotemia is one of the major forms of acute kidney injury in ward patients. 
But ATN is responsible for the majority of causes of acute renal failure in ICU 
patients. ATN in the ICU is usually multifactorial and is frequently part of 
multisystem organ failure syndrome. 
Prevention of AKI: 
Many factors predispose hospitalized patients to the development of AKI: 
volume depletion, drugs which affect renal blood flow (e.g., NSAIDs and Cox-2 
inhibitors), and the use of nephrotoxic medications and contrast dye. 
  
 
Although data are limited on treatments to prevent AKI20, it is prudent to 
carefully monitor volume status and maintain adequate hydration; 
discontinue (if possible) medications that are potentially nephrotoxic; 
choose alternate nonradiocontrast imaging techniques and use less 
nephrotoxic drugs. 
Morbidity and mortality associated with AKI. 
It is commonly thought that AKI from ATN is a completely 
reversible disorder. Recent data suggest that among patients who develop 
AKI in the ICU and require dialysis, 10% to 30% may require 
maintenance dialysis after discharge from the hospital. 
Another widely held opinion is that patients die with AKI, not from AKI. 
Numerous well-controlled studies have challenged this hypothesis and 
declared that after adjusting for comorbidities, the development of AKI 
in hospitalized patients is an independent and significant predictor of in-
hospital mortality. 
TABLE 2. MORTALITY IN ACUTE KIDNEY INJURY (AKI) 
 
Type of AKI Mortality 
AKI in the ICU associated with respiratory failure and 
the requirement of dialysis 
>90% 
AKI in the ICU 72% 
AKI in hospitalized patients, not in the ICU 32% 
 
 
 
AKI following intravenous 
contrast 
34% (compared to 7% in controls)  
Adjusted odds ratio of death: 5.5 
AKI following cardiac surgery 64% (compared to 4.3% in controls) 
 Adjusted odds ratio of death: 7.9 
AKI following administration of  
amphotericin B 
Adjusted odds ratio of death: 6.6 
 
So further studies are needed to understand the changing epidemiology of 
AKI, and also to find out the stage where we can intervene and reduce 
mortality 
 
 
 
 
  
AIMS AND OBJECTIVES 
 
 
1. To identify the incidence of acute kidney 
injury, their etiological factors, associated 
comorbid factors, interventions, and 
outcome in intensive care setting. 
2. To address the factors which predict the mortality in acute kidney injury. 
 
 
 
MATERIALS AND METHODS 
STUDY DESIGN: Prospective observational study.  
STUDY PLACE:  Intensive medical care ward (IMCW) in Stanley Medical College 
and hospital, Chennai.  
STUDY DURATION: May 2012 to October 2012 (6 months). 
STUDY POPULATION: Those who were admitted in IMCU in that 
period, and also having acute kidney injury. 
 
INCLUSION CRITERIA: 
According to RIFLE criteria 
 Patients who developed acute kidney injury during the hospital stay. 
 Patients who developed acute kidney injury in the community. 
 Patients who developed newer insult to a pre existing disease. 
 
 
EXCLUSION CRITERIA: 
 CKD patients who are in maintenance hemodialysis. 
 Patients who got admitted and expired within 24 hours. 
 Those who are not willing for the study. 
After getting approval from institutional ethical committee, the study was started 
in IMCW. Patients were given the consent form, and explanation was given. 
Those who were willing to participate were included in the study. 
 
 
  
HOW WAS THE STUDY CONDUCTED? 
In the 6 months patients who got admitted in IMCU were monitored for 
development of AKI, and those who admitted with AKI also included in the 
study. 
AKI was diagnosed based on RIFLE criteria. 
 We mainly consider the creatinine values for the diagnosis. But urine 
output was also taken into the data. 
 To find out AKI and differentiate acute from acute on renal disease by old 
records, ultrasonogram, other comorbid factors. 
 Elevation of creatinine from baseline values for each patient was   
     demonstrated. 
 To differentiate the prerenal from intrinsic renal, the clinical scenario, 
BUN:Cr ratio, FeNa were taken into consideration. 
 The associated comorbid factors, their course of stay, any significant 
events, the interventions they underwent were also documented. 
 In hospital mortality or improvement has been set as a final point. Attempts 
were made to find out the etiology in every case. 
 Those who were labelled with sepsis include sepsis due to urinary tract 
infection, soft tissue infection, pneumonia, CNS infections, and sepsis of 
unknown etiology. 
 Only medical cases were included in the study, the surgical, trauma cases, 
post operative cases were not included in the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
STATISTICAL ANALYSIS: 
Statistical analysis was performed using IBM SPSS version 20. All categorical 
data were expressed as percentage of the whole. The continuous variables were 
expressed as Mean ± Standard Deviation. 
Univariate analysis was performed using Chi Square test for categorical data and 
Mann Whitney U test was used for the continuous variables. The significance level 
was fixed at p<0.05. Adjusted Odds ratio with 95% Confidence interval was 
calculated as an estimate of the risk in those variables with statistically significant 
differences between the groups. Those variables which had p values less than 0.15 
in the univariate model entered the multivariate logistic regression in backward 
conditional method. The odds ratio (Exp[B]) and level of significance (p) were 
obtained in the regression analysis. Variables with p<0.05 were taken as 
significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
RESULTS 
The study was conducted in our IMCW for 6 months. The study results were  
as follows: 
During the six month period total number of IMCU admissions were 700. The total 
no patients who developed AKI were 83. 
The incidence of acute kidney injury was 118 per 1000 admissions. About 11.9% 
of the admissions had AKI in our IMCW . 
Among the 83 cases, 43 cases were expired and 40 were discharged from ICU. The 
mortality rate was 51.8%. 
 
TABLE 3. MORTALITY RATE: 
 
 
TOTAL CASES DISCHARGED EXPIRED MORTALITY 
83 40 43 51.8% 
  
 
 
 
 
TABLE 4. SEX DISTRIBUTION AND THEIR OUTCOME 
 
 
 
 
SEX 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
Female 31 37.3% 15 37.5% 16 37.2% 
Male 52 62.7% 25 62.5% 27 62.8% 
 Chi square (X)²=0.001 p=0.978 
 
In our study group, among the patients who developed AKI 52 were males and 
31 were females. The percentage was 62.65 for males, 37.34 for females. 
The percentage of patients developing AKI is more in males. Among the 
expired patients 27 were males and 16 were females with a percentage of 62.8 
for males and 37.2 for females respectively. 
But this had no statistical significance to predict that male gender is a risk factor 
for mortality in patients with AKI. 
  
 
 
TABLE 5. AGE DISTRIBUTION IN AKI. 
 
 
 
 
AGE 
GROUP 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
<30 8 9.6% 6 15.0% 2 4.7% 
30-39 9 10.8% 1 2.5% 8 18.6% 
40-49 19 22.9% 7 17.5% 12 27.9% 
50-59 25 30.1% 16 40.0% 9 20.9% 
>60 22 26.5% 10 25.0% 12 27.9% 
 
Among the AKI patients, 25 were in the age group of 50-59. 22 were in the age 
group of more than 60. Among the expired those who were more than 60 and those 
between 40 -49 had increased percentage of mortality. 
TABLE 6. PRIMARY CAUSE FOR ADMISSION 
 
 
ADMITTED FOR 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
ADD 3 3.6% 3 7.5% 0 
 
CVD 7 8.4% 3 7.5% 4 9.3% 
CNS 8 9.6% 5 12.5% 3 7% 
MALARIA 1 1.2% 1 2.5% 0 
 
DCLD 13 15.6% 4 10% 9 20.9% 
FULMINANT 
HEPATITIS 
4 4.8% 1 2.5% 3 7% 
RENAL 10 12% 4 10% 6 14% 
SEPSIS 31 37.2% 15 37.5% 16 37.2% 
CuSO4 2 2.4% 2 5% 0 
 
SOLANINE 1 1.2% 0 
 
1 2.3 
PANCREATITIS 1 1.2% 1 2.5% 0 
 
MALIGNANCY 1 1.2% 0 
 
1 2.3 
HYPOKALEMIA 1 1.2% 1 2.5% 0 
 
 
 
The above table shows the various diseases for which patient got admitted. Among 
these, the patients who got admitted for sepsis, were more prone to develop acute 
kidney injury. In the 83 patients, 31 were admitted for sepsis with a percentage of 
37.2%. 
13 patients who got admitted for decompensated liver disease developed AKI with 
a percentage of 15.6%. 
Among the 83 AKI‘s, 10 were admitted for primary renal problem with a 
percentage of 12%. Among the expired patients, 37.2 % were admitted for sepsis 
and 20.9% were admitted for DCLD. The remaining were CNS 7%, CVD 9.3% 
and fulminant hepatitis was 7%. 
Others were ADD, malaria, pancreatitis, copper sulphate, solanine poisoning and 
hypokalemia. 
  
 
 
 
 
TABLE 7. COMORBID FACTOR – SYSTEMIC HYPERTENSION IN AKI. 
 
 
 
 
SHT 
 
TOTAL 
 
OUTCOME 
 
Discharged Expired 
Number Percent Number Percent Number Percent 
Yes 23 27.7% 11 27.5% 12 27.9% 
No 60 72.3% 29 72.5% 31 72.1% 
 Chi square (X)²=0.002 p=0.967 
 
Among 83 AKI patients 23 patients had SHT, 60 patients didn‘t have hypertension  
with a percentage of 27.7 and 72.3% respectively. In the expired group of patients,  
12 had SHT and 31 did not have that, with a percentage of 27.9 and 72.1%   
respectively. 
These values did not have statistical significance with a P value of 0.967. 
  
 
 
 
TABLE 8. COMORBID FACTOR – T2DM IN AKI. 
 
 
 
DM 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
Yes 34 59.0% 17 42.5% 17 39.5% 
No 49 41.0% 23 57.5% 26 60.5% 
 Chi square (X)²=0.075 p=0.784 
 
Table 3 shows 34 out of 83 patients had diabetes mellitus and 49 don‘t have diabetes 
with a percentage of 59.0 and 41.0% respectively. Among the expired patients,  
17 had diabetes and 26 on the other side. 39.5% of the expired individuals had diabetes.  
60.5% don‘t have this comorbid factor. 
This is not statistically significant with a P value of 0.784. 
  
 
 
TABLE 9. SPOT URINE SODIUM IN AKI – AN ANALYSIS 
 
 
 
 
URINE 
SODIUM 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
<40 28 33.7% 9 22.5% 19 44.2% 
>40 55 66.3% 31 77.5% 24 55.8% 
 
Chi square (X)² = 
4.360 
p=0.037* 
 
 
 
In 83 patients with AKI, 28 patients had spot urine sodium less 
than 40 and 55 patients had more than 40 and their percentage 
was 33.7, 66.3% respectively. 
24 patients, who died had spot urine sodium more than 40 and 19 had less than 40 with a 
percentage of 
55.8 and 44.2% respectively. This had a statistical 
significance with a P value of 0.037, which implies that spot 
urine sodium >40 is a predictor of mortality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
TABLE 10. SIGNIFICANCE OF FeNa IN AKI 
 
 
 
 
 
FeNa 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
<1 29 34.9% 16 40.0% 13 30.2% 
>1 54 65.1% 24 60.0% 30 69.8% 
 
Chi square (X)²=0.870 p=0.351 
 
 
In total AKI patients 54 had FeNa >1 and 26 had less than 1.  
The percentage was 65.1% and 34.9%. 30 out of 43 expired individuals  
had FeNa >1 and 13 individuals had <1%. 
The percentage was 69.8 and 30.2% respectively. Although the death rate was 
more in the patients with FeNa >1, it was not statistically significant. The p 
value was 0.351. 
  
 
TABLE 11. URINE ABNORMALITIES IN AKI 
 
 
 
 
URINE 
ROUTINE 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
NORMAL 37 44.6% 14 35.0% 23 53.5% 
SEDIMENT 46 55.4% 26 65.0% 20 46.5% 
 
Chi square (X)²=2.867 p=0.090 
 
Among the 83 patients 46 had active sediments in the urine and 37 
had no abnormalities with a percentage of 55.4 and 44.6% respectively. 
 
In the 43 expired patients, 20 had active sediments and 23 had no sediments 
with 46.5% and 53.5% respectively. 
The association between this urinary abnormality and death rate is not 
statistically significant with a p value of 0.090. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
TABLE 12. URINE OUTPUT – A PREDICTOR OF MORTALITY 
 
 
 
 
URINE 
OUTPUT 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
NON 45 54.2% 29 72.5% 16 37.2% 
OLIGURIC 
      
OLIGURIC 38 45.8% 11 27.5% 27 67.8% 
 
Chi square 
(X)²=10.398 
p=0.001* 
 
 
Out of 83 patients, 38 were oliguric and 45 were non oliguric with 45.8% and 
54.2% respectively. Among the expired 27 were oliguric and 16 were non 
oliguric. The percentage was 67.8% and 37.2% respectively. Oliguria was one 
of the predictor of mortality with statistical significance. 
The P value was 0.001. 
  
 
TABLE 13. HYPOTENSION AND AKI 
 
 
HYPOTENSION 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
NO 43 51.8% 27 67.5% 16 37.2% 
YES 40 48.2% 13 27.5% 27 62.8% 
 
Chi square 
(X)²=7.615 
p=0.006* 
 
Among the patients with AKI 40 persons had hypotension and 43 persons don‘t 
have hypotension during the course of hospital stay with a percentage of 48.2% 
and 51.8%. 
Out of 43 expired individuals, 27 had hypotension and 16 didn‘t have that.   
The percentage was 62.8%, 37.2%. 
This was statistically significant with a p value around 0.006. 
Hypotension is a predictor of mortality in AKI. 
  
TABLE 14. VENTILATOR SUPPORT IN AKI 
 
 
 
VENTILATORY 
SUPPORT 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
NO 46 55.4% 27 67.5% 19 44.2% 
YES 37 44.5% 13 27.5% 24 55.8% 
 
Chi square 
(X)²=4.559 
p=0.033* 
 
In total no AKI patients, 37 needed ventilator support and 46 didn‘t need that 
support. The percentage was around 44.5 and 55.4% respectively. 
In 43 expired patients, 24 were on ventilator support and 19 were not on 
ventilator with the percentage around 55.8% and 44.2%. 
        This increased percentage had statistical significance with p value of 0.033. 
         Thus ventilator support in AKI patients is a predictor of mortality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE 15. DISTRIBUTION OF ACUTE AND ACUTE ON CHRONIC 
RENAL DISEASE 
 
 
 
DURATION 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
ACUTE 46 55.4% 21 52.5% 25 58.1% 
ACUTE ON 
CHRONIC 37 44.6% 19 47.5% 18 41.9% 
 Chi square 
(X)²=0.267 
p=0.605 
 
 
 
Patients presented as acute renal failure without pre-existing renal disease were 
46 (out of 83) which was 55.4%. Those who had underlying renal disease 
presenting as acute on pre existing renal disease were 37 out of 83(44.6%). 
Among the expired, 25 were labelled as acute and 18 were have acute on 
chronic renal disease with 58.1% and 41.9% respectively. 
Although there is increased percentage of acute presentation, it had no 
statistical significance. The p value was 0.605. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE 16. DISTRIBUTION OF TYPE OF AKI: 
 
 
 
 
PATHOLOGY 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
PRE-RENAL 25 30.1% 14 35.0% 11 25.6% 
INTRINSIC-RENAL 58 69.9% 26 65.0% 32 74.4% 
 
Chi square 
(X)²=0.873 
p=0.350 
 
 
Among the 83 patients, 58 had intrinsic AKI and 25 had prerenal AKI with a 
percentage of 69.9%, 30.1%. 
In 43 expired patients 32 had intrinsic renal and 11 had pre renal disease. The 
percentage was 74.4% and 25.6%. 
This is not statistically significant with a p value of 0.350. 
  
 
 
 
 
 
TABLE 17. DISTRIBUTION OF SEVERITY IN AKI 
 
 
 
RIFLE 
CATEGORY 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
RIFLE-R 3 3.6% 2 5.0% 1 2.3% 
RIFLE-I 36 43.4% 17 42.5% 19 44.2% 
RIFLE-F 44 53.0% 21 52.5% 23 53.5% 
 
Chi square (X)²=0.427 p=0.808 
 
Among the AKI patients, 3 were in the risk category, 36 in the injury, 44 in 
the failure category with the percentage of 3.6%, 43.4%, 53.0% 
respectively. 
In the expired patients, 23 were in the failure category, 19 were in the injury 
category, 1 in the risk category. The percentages were 53.5%, 44.2%, 2.3% 
respectively. 
 
This increase in ‗failure‘ percentage was not statistically significant to 
predict as a marker of mortality. P value was 0.808. 
  
 
 
 
 
TABLE 18. INTERVENTIONS IN AKI 
 
 
 
 
 
DIALYSIS 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
NONE 58 69.9% 29 72.5% 29 67.4% 
PD 9 10.8% 5 12.5% 4 23.3% 
HD 16 19.3% 6 15.0% 10 9.3% 
 
Chi square (X)²=1.004 p=0.605 
 
 
Out of the 83 patients, 58 did not undergo any procedures. 16 underwent 
hemodialysis and 9 underwent peritoneal dialysis with the percentages 19.3% 
and 10.8% respectively. 
In the expired patients, 10 underwent hemodialysis, 4 on peritoneal dialysis, 29 
were not on any support with 9.3%, 23.3%, 67.4% respectively. 
 
 
These percentages were not statistically significant as the p value was 0.605 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 19. THE MEAN FOR AGE, SPOT Na, FeNa, CREATININE 
 
 
 
PARAMETER 
 
TOTAL 
OUTCOME Mann 
Whitney 
U test Discharged Expired 
Mean SD Mean SD Mean SD P value 
AGE 49.96 14.23 50.28 16.13 49.67 12.39 0.616 
INITIAL 
CREATININE 
2.69 1.69 2.78 1.99 2.60 1.37 0.774 
PEAK 
CREATININE 
4.48 2.38 4.51 2.46 4.46 2.32 0.845 
SPOT SODIUM 61.80 29.83 67.48 29.77 56.51 29.24 0.082 
FeNa 1.14 0.37 1.12 0.36 1.17 0.37 0.601 
 
 
 
 
 
 
The mean age for the patients developing AKI was 49.96 with SD of 14.23. 
Among the expired mean age was 49.67 with SD of 12.39. Mean for the initial 
creatinine was 2.69 with 1.69 SD. For the expired 2.60 was the mean initial 
creatinine. 
For the peak creatinine, the mean was 4.48. Regarding the FeNa,  
the  mean was 1.14 with SD 0.37. 
  
 
TABLE 20. CAUSES OF AKI 
 
 
AKI 
CAUSE 
 
TOTAL 
OUTCOME 
Discharged Expired 
Number Percent Number Percent Number Percent 
DRUG 2 2.4% 2 5.0% 0 0% 
GN 4 4.8% 2 5.0% 2 4.7% 
HRS 6 7.2% 1 2.5% 5 11.6% 
HUS 6 7.2% 2 5.0% 4 9.3% 
INFECTION 38 45.8% 17 42.5% 21 48.8% 
RHABDO 1 1.2% 1 2.5% 0 0% 
SHOCK 22 26.5% 12 30.0% 10 23.3% 
TOXIN 4 4.8% 3 7.5% 1 2.3% 
 
 
 
Among the causes, infection top the list with 38 cases (45.8%). Next come 
the shock due to various causes around 22 cases (26.5%). Other etiologies 
include HRS and HUS (7.2% each), toxins and glomerulo nephritis (4.8% 
each). 
Among the expired patients, infection top the list and next comes shock, 
with 48.8%, 23.3% respectively. HRS was 11.6% among the expired. 
  
 
 
 
 
TABLE 21. MULTIVARIATE LOGISTIC REGRESSION TO PREDICT 
MORTALITY IN AKI 
 
 
S.No PARAMETER ODDS RATIO 
(EXP[B]) 
SIGNIFICANCE 
(p) 
1 Oliguria 9.756 <0.001 
2 Hypotension 6.490 0.003 
3 Mechanical Ventilation 2.288 0.135 
 
Multivariate logistic regression analysis was performed to analyse the 
parameters which were significantly influencing mortality in AKI in the 
univariate model (with p value <0.05). Oliguria and hypotension were the 
factors which were more likely to predict mortality in AKI with Odds ratio of 
9.7 and 6.5 respectively. Mechanical Ventilation also had an Odds ratio of 2.3 
in predicting mortality, but it fell short of significance in the final regression 
model (p=0.13). 
  
 
DISCUSSION 
Acute kidney injury is a clinical condition that complicates other diseases and 
when it is associated with other diseases the mortality and morbidity will 
increase. 
Also it can occur as a primary problem with its complications resulting in 
mortality and morbidity. Acute kidney injury is caused by various etiological 
factors and environmental factors. After identifying AKI, the foremost thing is 
to find out the cause for it. 
There are many studies, that are ongoing in the acute kidney injury correlating 
with various comorbibities. Already plenty of studies have been done on this 
one, still we are in a state to need know more about it. 
Studies were done regarding the epidemiology, aetiology, severity, and 
outcome of patients on dialysis. Also AKI had been studied to find the 
heterogenous factors in relation to adult and paediatric population, in urban and 
tropical setting, also in developing countries and developed countries. 
To assess the severity of the disease, various criterias were developed to 
manage them effectively. Studies had been done on these criterias to test the 
efficacy of the criteria in predicting the disease course. 
AKI is traditionally classified into three: the community, in hospital, and in 
ICU. The predominant factors causing AKI were different in different settings. 
Also the mortality is varying with each entity. 
There are plenty of literature on acute kidney injury in various scenarios in our 
western counterpart. On the contrary, there were very limited studies in our 
Indian population, especially in the southern side. 
  
 
We conducted the study in the intensive medical care ward, in Stanley medical 
college from may 2012 to October 2012. The total admissions were 700 during 
that period. Of whom 83 patients developed AKI. The patients who stayed less 
than 24 hours excluded from the study and also those who already labelled as 
stage 5 CKD on hemodialysis. 
The incidence of AKI in our ICU was 11.9%. According to the western 
literature the range of incidence was 5% – 15 % which is comparable to our 
data. 
Regarding the sex distribution 62.7% were males, 37.3% were females. There is 
a male predominance in the data which implies male were prone to development 
of AKI. Also among the expired patients 62.8% were males. But these were not 
statistically significant. 
In our study age distribution is more centred around 50 – 59 years of age and in 
individuals more than 60 years. But among the expired individuals, persons 
aged >60 years tops the list along with the persons between 40- 49. These were 
not significant to take as a predictor of mortality. 
Comorbid factors like diabetes, hypertension were less in the AKI patients. 
More patients developed AKI without these comorbidities. The patients without 
diabetes and hypertension were more on the expired group. 
The P values for these were more than 0.05. 
Spot urine sodium is a marker used in AKI patients. If it is more than 40 which 
implies tubular dysfunction and intrinsic renal involvement, in the absence of 
diuretic usage. In 83 patients, 66.3% had 
  
 
spot na >40. Also 77.5% expired persons had spot urine sodium > 40. Although 
it is not fool proof for tubular dysfunction, it proves as predictor of mortality in 
AKI patients, which is statistically significant. 
Manytimes urinary abnormalities in AKI helps in diagnosis of the disease, 
which is more commonly in glomerular diseases and in UTI. In the study group, 
55.4% had active sediments in the urine and in the mortality group 46.8% had 
active sediments. But these were not statistically significant. 
The renal failure patients were usually categorized into oliguric, nonoliguric. It 
neither differentiates acute and acute on chronic nor does find prerenal or 
intrinsic renal. Nearly 45.8% was oliguric in the AKI patients and in the expired 
group it was 67.8% which is statistically significant as a predictor of mortality. 
Oliguria usually occurs in various diseases like cardiac failure, hypovolemic 
shock, other than renal failure. If it is associated with AKI it is a significant 
factor in predicting the mortality. 
In acute kidney injury patients 48.2% were hypotensive, and in the expired 
group 62.8 % were hypotensive. Hypotensive individuals include those persons 
who developed hypotension atleast one time during their ICU stay. This was 
statistically significant with a p value of 0.006, which predicts the mortality. 
Thus hypotension in AKI is a significant factor in predicting the mortality. 
In ICU setting, patients will be connected to the ventilator due to various 
reasons. Among the AKI patients in our study 44.5% were connected to the 
ventilator and in the expired 55.8% were connected to the ventilator. Ventilator 
support is a predictor of mortality in AKI patients in ICU with significant P 
value of 0.033. 
  
 
Acute kidney injury can occur on previously normal patients or in patients with 
underlying renal disease. In our study 55.4% presented as acute and 44.6% were 
acute on chronic renal disease. It doesn‘t have any influence on mortality. 
Usually underlying diabetes or hypertension had some proteinuria which results 
in renal injury. 
We categorized the patients into prerenal and intrinsic renal based on clinical 
scenario, fena, hydration status and creatinine measurements. In AKI patients 
69.9% were intrinsic renal and 30.1%were labelled as prerenal. Among the 
expired patients, 74.4% were intrinsic renal. Although it is not statistically 
significant, there were more intrinsic renal failure in the expired group. 
Acute kidney injury patients can be managed conservatively or they may 
undergo dialysis. In our study patients, 69.9% was managed conservatively and 
19.3% were on HD, and 10.8% on PD. Only 9.3% of the individuals on HD 
expired but the ratio is not statistically significant. 
In acute kidney injury the severity is assessed with the help of RIFLE criteria 
which has more sensitivity. Many studies have proved that it is an independent 
predictor of mortality. But in our study among the AKI patients 53% were in 
the failure category, 43.4% were in injury category, and 3.6% in risk category . 
In the expired group, 53.5% were in the failure category and 44.2% in the injury 
category, but this not statistically significant. This may be due to less sample 
size and also less numbers in the R category. 
Among the continuous variables like age, creatinine, spot Na, the mean and 
standard deviation were calculated. The mann whitney U test was used to find 
out the significance of the variable in predicting the mortality. The mean for 
age, peak creatinine, spot sodium were 49.96, 4.48, 61.80 respectively. The 
mean age among the expired was 49.67, spot sodium was 56.51. 
  
 
Regarding the FeNa the mean was 1.17 with the standard deviation of 0.37 but 
this is also not statistically significant. 
In the intensive care setting, patient will be admitted for various diseases 
involving various organs. Certain diseases were more prone for developing 
AKI. In our ICU, infection causes 45.8% of AKI. shock causes 26.5% of the 
cases, remaining cases were caused by the hepato renal syndrome, haemolytic 
uremic syndrome, glomerulonephritis, toxins, and drugs in decreasing order of 
percentage. 
 
 
Among the expired, infection was the predominant cause of AKI with a 
percentage of 48.8% and shock causes 23.3%. The others were HRS, HUS, 
glomerulonephritis, toxin in decreasing order. Infection is the major cause of 
AKI in our study, which has been confirmed by other many studies, next was 
the shock from various causes which results in AKI.Infection is also the major 
cause of mortality in patients with AKI. 
Copper sulphate poisoning is the most common cause of toxin induced AKI in 
our ICU. But the mortality is less in copper sulphate due to forced alkaline 
diuresis as a treatment modality. 
There were only two cases of AKI occurred due to drugs. But there were no 
deaths. Due to more number of decompensated liver disease patients getting 
admitted in our ICU, a significant number of cases of AKI were caused by 
HRS, apart from infection causing AKI in the DCLD patients. 
The above told statistical analysis were done by the univariate analysis, pearson 
chi- square test to predict the mortality with the associated variables. Further to 
increase the statistical significance, the factors 
  
 
which predict the mortality with significance according to univariate analysis 
were included in the multivariate regression analysis. It confirmed that oliguria 
and hypotension significantly predicted the mortality. The mechanical 
ventilation predicts with less significance. 
Hou et al30 did a study on AKI in early days and reported a incidence of 4.9 
percentage which was less comparable to the present status and the mortality 
rate was 25%. Few years later, Nash et al31 found that the inhospital AKI 
incidence was around 7.2%, and the mortality rate was 19.4%. The predominant 
causes were decreased perfusion, toxins and major surgeries. These were the 
earlier data. 
Sean bagshaw et al reported from a multicenter study which was conducted in 
Australian ICUs that,incidence of AKI in ICU was 5.2% with a yearly increase 
of 2.8% the mortality rate of AKI patients was 42.7%. The total duration of stay 
was more in the survivors than those expired. 
Schaefer JH et al25 found out the outcome predictors of acute kidney injury in 
ICU setting. They reported that the mortality rate was 56.7% in AKI patients in 
ICU. Also they found mechanical ventilation, hypotension were the significant 
predictors of mortality. The results of this study closely resembled our study 
results. 
 
Brivet FG et al26 did a multicenter evaluation of AKI in ICU. They preferably 
analysed the severe AKI. Their sample size was 360. Their results showed a 
mortality rate of 58%, which is higher than that of our study. The predictor of 
mortality were age, oliguria, sepsis, severity of illness, delayed renal failure, 
and previous hospitalisation. The predictors of mortality in this study partially 
resembles our study. Among the AKI patients 16 were prerenal, 282 were 
intrinsic renal, and 17 were post renal. As in our study the intrinsic renal group 
was more. 
Abosaif NY et al27 did a study on the outcome of AKI patients in intensive 
care setting according to RIFLE. They had 60 patients in risk category, 56 in 
injury category, 43 in failure category. They reported that ,those patients with 
failure category had increased death rate. They confirmed the ability of RIFLE 
criteria in predicting mortality. Also they found the RIFLE is correlating with 
the severity illness scores like APACHE II and SAPS score. In our study there 
were less patients in the R category. Also we 
couldn‘t prove that RIFLE criteria predicts the mortality. As the severity 
increases the death rate doesn‘t show a rise in statistically significant manner. 
 
 Chologitas et al28 did a study among the decompensated liver disease patients 
in ICU to find out the correlation of mortality with the severity of AKI. The 
overall mortality was 61.2%. They analysed with multivariate regression 
method, which showed RIFLE is a independent factor associated with 
mortality. But it is less useful than other severity scores like SOFA, APACHE 
II. 
The famous PICARD32 (the program to improve care in acute renal 
disease) study was conducted in 5 centers as a prospective observational 
cohort study over 3 years . They found a incidence of 25% - 60%, and reported 
a heterogenicity of distribution of AKI among all aspects. The common causes 
include ATN, intrinsic renal disease due to sepsis, nephrotoxin administration, 
cardiac diseases, and liver diseases. This mainly gave a conclusion of changing 
trends in the epidemiology of AKI. 
The BEST study33 (the beginning and ending supportive therapy for the 
kidney) is the largest prospective cohort study conducted over this topic. The 
mortality rate was around 60%. The predominant causes were septic shock, 
postoperative states, cardiac diseases, and toxin administration. The predictors 
of mortality were old age, sepsis, oliguria, blood urea nitrogen, severity score. 
Our study partially resembles this study in certain variables. 
Ostermann et al29 evaluated the utility of RIFLE in ICU setting. They found 
that AKI had an incidence of 35.8%. Among that17.2% were in risk category, 
11% in I category and 7.6% in failure category. The mortality was more in the 
failure category. 
RIFLE criteria predicts the outcome of renal failure but the associated multi 
organ dysfunction, severity of illness for which patients are admitted had a 
more significant impact in determining the outcome. 
Cruz et al. did a prospective study and calculate the AKI incidence in ICU 
setting. It was around 10.8% the incidence closely resembles our study and 
3.3% were required dialysis. Among the AKI patients, 19% were in Risk, 35% 
in Injury, and 46% in Failure category. As in our study this study has also more 
number of in failure category. The most common causes of AKI were prerenal 
38.9% and sepsis 25.6%. 
In the Indian studies for example, study on hospital acquired AKI conducted 
by anupama kaul et al over 12 months in a prospective manner, showed that 
baseline creatinine value, maximum RIFLE category, decreased urine output, 
metabolic acidosis were the predictors of mortality. They concluded that the 
epidemiology of AKI has been more or less similar to the western data. 
  
 
Recently D Juneja et al did a study in ICU of a tertiary care hospital in New 
Delhi. They reported that patients with increased severity of AKI according to 
RIFLE had increased mortality. The mortality for the patients in failure group 
was 38% which is lower than our mortality rate. 
Sural S et al did a study on acute kidney injury in ICU. Their results showed, 
the mortality rate was around 90%. The primary reasons for admissions were 
sepsis and multi organ dysfunction. They found out MODS is the only 
predictor of mortality with statistical significance. 
Although the mortality rate in our study is high, it is comparable to the western 
data. Among the AKI patients, more common reasons for admission in ICU 
were sepsis, decompensated liver disease and cardio vascular diseases. 
Although many studies has been proved the RIFLE criteria as a predictor of 
mortality our study couldn‘t prove that. This may be due to less sample size. 
Analysis done by multi variate regression showed oliguria, hypotension were 
the significant predictors of mortality. Ventilator support as a predictor of 
mortality has somewhat less statistical significance. 
LIMITATIONS OF OUR STUDY: 
 The sample size is small. 
 It has been done in a single center. 
 The postoperative cases, trauma cases, surgical cases were not been 
included. 
 We didn‘ t use other severity scores like APACHEII, SAPS, SOFA. 
 Only the in hospital mortality has been calculated. 
 We didn‘t take urine output in consideration to diagnose AKI. 
 Single group of population has been studied, so we cannot find out 
heterogenous epidemiology of acute kidney injury. 
 
 
 
 
 
 
 
 
 
  
 
SUMMARY AND CONCLUSION 
Acute kidney injury, a common problem in ICU, has a strong impact in the 
mortality and morbidity. Although there are rampant studies available in the 
west, there are less than a handful of study in south India. We had few 
similarities and dissimilarities in comparison to the western literature. 
 
Results comparable to study done elsewhere: 
 Incidence of AKI is11.7% 
 Mortality rate is 51.8% 
 Most common causes of AKI are sepsis, shock, and hepatorenal 
syndrome. 
 Predictors of mortality are persistent oliguria requiring renal 
replacement therapy, hypotension, ventilator support. 
 Incidence of AKI is more than acute on chronic kidney disease. Results 
dissimilar to study done elsewhere: 
 Severity of AKI as per RIFLE did not correlate with mortality. 
 Patients in RIFLE(R) were less in number. 
 Age had no say in the mortality. 
 Coexistent diabetes and hypertension did not influence the mortality. 
There is one parameter, which is not taken into consideration in other 
studies (to the best of my knowledge), which is a independent predictor of 
mortality, is spot urine sodium (> 40). Further studies on large scale are 
required to prove its significance. 
In short, infections and hypotension are the most common cause of 
mortality. Diligent care should be taken to find the etiology and to maintain 
fluid homeostasis. Patients who are oliguric and/or on ventilator should be 
managed with special precautions, as they are significant predictors of 
mortality. 
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                                  PROFORMA 
• NAME :  
• SL. NO: 
• AGE /SEX: 
• IP NO: 
• DATE OF ADMISSION: 
• DATEOF IMCU ADMISSION 
• DATE OF DISCHARGE: 
 
• CLINICAL COURSE 
 URINE ANALYSIS 
 
URINE ROUTINE  
 
SPOT URINE Na+ 
 
URINE PCR 
FeNa 
 
 CBC 
 RBS 
 RFT 
 
 ADMISSION PEAK DISCHARGE 
UREA    
CREATININE    
 
 
 
 
 
 
 
 
 
 
  
 ELECTROLYTES: 
 
 
 URINE OUTPUT 
 
 
 ABG 
 
 
 USG ABDOMEN 
 
 
 OTHER RELEVANT INVESTIGATIONS 
 
 
 DIAGNOSIS: 
 
 
 DIALYSIS: PD/HD 
 
 
 OUTCOME: DISCHARGED / EXPIRED 
  
 
KEY TO MASTER CHART 
 
 
 
 
SHT Systemic Hypertension 
DM Diabetes Mellitus 
INIT-CR Initial Creatinine 
PEAK- CR Peak Creatinine 
DIS-CR Discharge Creatinine 
FENA Fractional Excretion of Sodium 
VENT Ventilatory Support 
CHRO Chronicity 
 
  
 
 
SL.No. NAME AGE AGEGROUP SEX DURATION ADMIN_FOR SHT DM INIT_CR PEAK_CR DIS_CR SPOT_NA FENA UROUTINE URINE HYPOTENSI VENT PATH CHRO RIFLE AKI_CAUSE DIALYSIS OUTCOME 
1 Hussian 58 50-59 M 12 CVD Y Y 1.60 7.00 3.40 40.00 1.20 A+ Non No No IR A/C F Drug No Dis 
2 Subbbiah 73 >60 M 5 Sepsis Y N 2.20 5.00 0.00 70.00 1.10 Nor OLI No Yes IR A/C F Infection PD Dis 
3 Sivalingam 55 50-59 M 18 CVD Y N 1.10 8.20 0.00 80.00 1.03 A+ Non Yes Yes IR acute F Shock PD Dis 
4 Rajarajan 36 30-39 M 20 DCLD N N 0.90 5.60 0.00 41.00 1.50 A2+/RBC+ OLI No No IR acute F Infection No Dis 
5 Ravi 40 40-49 M 5 DCLD N N 1.30 1.80 1.20 28.00 0.90 Nor Non No No PR acute R Infection No Dis 
6 Ramamurthy 65 >60 M 3 CVD N N 1.50 2.20 0.00 17.00 0.70 Nor OLI Yes Yes PR acute I Shock No Exp 
7 Venkatesan 56 50-59 M 3 Sepsis Y N 2.80 6.10 2.20 80.00 1.30 A2+/PUS Non No Yes IR A/C F Infection HD Dis 
8 Subramanian 54 50-59 M 3 CVD N N 1.40 2.80 0.00 40.00 0.70 Nor OLI Yes Yes PR acute I Shock No Exp 
9 Praveen 27 <30 M 10 Sepsis N N 2.30 2.30 0.90 56.00 0.60 Nor Non No No PR acute I Infection No Dis 
10 Mani 49 40-49 M 7 Sepsis N Y 1.60 3.60 1.30 100.00 0.90 A+ Non No No PR A/C I Infection No Dis 
11 suseela 68 >60 F 4 Sepsis Y Y 1.20 3.10 0.00 60.00 1.20 PUS+ OLI Yes Yes IR A/C I Infection No Dis 
12 baby francina 53 50-59 F 9 Sepsis Y Y 6.40 6.40 6.10 155.00 1.10 A+/PUS+ Non No Yes IR A/C F Infection PD Dis 
13 kathija 42 40-49 F 25 CNS Y Y 1.90 2.50 1.30 100.00 0.80 A+ Non Yes No PR A/C I Shock No Exp 
14 sharmila 18 <30 F 12 CNS Y N 1.40 3.20 1.80 91.00 1.20 Nor Non No No IR A/C I Rhabdo No Dis 
15 saraswathy 57 50-59 F 6 Renal N N 4.20 4.20 1.80 68.00 0.90 RBC+ OLI No No IR acute F GN HD Dis 
16 ayarnisha 54 50-59 F 4 Sepsis Y Y 0.60 4.50 0.00 68.00 1.40 A+/PUS+ Non No Yes IR A/C F Infection No Dis 
17 Lakshmi 79 >60 F 4 Sepsis N Y 3.70 4.10 0.00 95.00 1.40 A+/PUS+ Non No Yes IR A/C F Infection No Dis 
18 muniammal 62 >60 F 7 CNS Y N 1.70 3.50 1.90 18.00 1.30 A+ Non No No IR A/C I Drug No Dis 
19 Rani 50 50-59 F 3 Sepsis N N 6.20 8.00 0.00 80.00 1.10 PUS+ OLI No Yes IR acute F Infection PD Dis 
20 Kalaiyarasan 40 40-49 M 3 CVD N N 1.70 4.80 0.00 15.00 1.10 Nor OLI Yes Yes IR acute F Shock No Dis 
21 Rajesh 22 <30 M 8 Pancreatitis N N 8.70 12.00 0.00 80.00 1.30 A+/RBC+ OLI No No IR A/C I HUS HD Dis 
22 Deivanayagi 62 >60 F 8 Sepsis N Y 2.50 2.60 1.10 60.00 0.70 A+ Non Yes No PR A/C I Shock No Dis 
23 Rukmani 65 >60 F 6 Renal N Y 6.20 10.20 3.20 40.00 1.10 RBC+ OLI No No IR acute F HUS HD Dis 
24 Elumalai 70 >60 M 9 DCLD N N 1.80 4.90 2.00 90.00 1.60 Nor OLI No No IR acute F HRS No Dis 
25 Vadivel 50 50-59 M 7 Sepsis N Y 0.80 2.80 1.40 133.00 0.90 A+ Non Yes No PR acute I Shock No Dis 
26 Devaki 70 >60 F 14 CNS N Y 2.20 4.00 0.00 80.00 1.70 PUS+ Non No Yes IR A/C F Infection No Dis 
27 Ramasamy 53 50-59 M 3 DCLD N Y 1.80 1.80 1.30 40.00 0.90 A+ Non Yes No PR acute I Shock No Dis 
28 Akbar Ali 44 40-49 M 5 Hypokalemia N N 3.70 5.20 1.50 57.00 1.40 Nor Non No Yes IR acute F Toxin PD Dis 
29 Raja 40 40-49 M 12 CuSo4 N N 0.90 1.80 1.10 110.00 1.80 A+/RBC+ Non No No IR acute I Toxin No Dis 
30 Mythili 50 50-59 F 3 Sepsis N Y 2.70 2.70 2.10 78.00 1.60 A+ Non No Yes IR A/C I Infection No Dis 
31 muniammal 40 40-49 F 7 Sepsis N Y 2.30 4.20 1.80 80.00 1.50 Nor OLI No No IR A/C F Infection No Dis 
32 Theresa 66 >60 F 9 CNS Y N 0.80 1.60 0.00 40.00 0.80 Nor Non Yes Yes PR acute R Shock No Exp 
33 Subramani 52 50-59 M 5 Sepsis N Y 3.90 4.20 0.00 80.00 1.80 A+/PUS+ Non No Yes IR acute F Infection No Dis 
34 Murugan 57 50-59 M 14 CNS N N 0.70 2.20 0.90 28.00 0.70 Nor Non Yes No PR acute R Shock No Dis 
35 Jayaraj 25 <30 M 6 Malaria N Y 5.00 8.80 2.40 80.00 1.70 A+/RBC+ OLI No No IR acute F Infection HD Dis 
36 Parameswari 40 40-49 F 3 Renal N N 2.10 2.40 1.00 60.00 1.20 A+/PUS+ Non No No IR A/C I Infection No Dis 
37 Muthukrishna 55 50-59 M 6 Renal N N 8.30 8.30 4.40 72.00 0.70 A+/RBC+ Non No No IR acute F GN HD Dis 
38 Jenath 50 50-59 F 3 Sepsis Y Y 0.90 2.50 0.00 100.00 2.00 PUS+ OLI Yes Yes IR A/C I Infection No Exp 
39 Mathu 56 50-59 M 5 DCLD N N 2.20 4.90 0.00 28.00 1.10 Nor Non Yes Yes IR acute F Infection PD Exp 
  
 
 
40 Sumathi 34 30-39 F 3 Renal N N 3.40 7.00 2.80 42.00 1.20 RBC+ OLI No No IR acute F HUS HD Exp 
41 Kurshid 56 50-59 F 6 Renal Y N 2.10 7.00 4.80 54.00 0.80 A+/RBC+ OLI No No IR A/C F GN HD Exp 
42 Esther 50 50-59 F 5 Sepsis N Y 7.10 8.70 2.10 40.00 1.20 A+/PUS+ OLI No No IR A/C F Infection HD Exp 
43 Kasthuri 60 >60 F 6 Renal N Y 3.80 6.20 2.60 40.00 1.20 A+/RBC+ OLI No No IR acute F HUS HD Exp 
44 Govindhamm 45 40-49 F 6 Sepsis Y Y 3.20 5.80 1.30 74.00 1.30 A+/PUS+ OLI Yes No IR acute F Infection HD Exp 
45 Shanmugam 38 30-39 M 6 Sepsis N Y 2.10 2.90 0.00 27.00 1.10 Nor Non Yes Yes IR A/C I Infection No Exp 
46 Kabbar 62 >60 M 3 Sepsis N N 2.60 3.50 0.00 22.00 1.10 Nor OLI Yes Yes IR A/C F Infection No Exp 
47 Ebenezer 80 >60 M 5 CNS Y N 1.50 4.20 1.80 20.00 0.50 Nor Non Yes No PR A/C F Shock No Dis 
48 Francis 45 40-49 M 3 malignancy N Y 1.60 2.50 0.00 44.00 0.60 Nor Non Yes No PR acute I Shock No Exp 
49 Valli 35 30-39 F 3 solanine N N 1.60 2.00 0.00 60.00 1.30 Nor Non Yes Yes IR acute I Toxin No Exp 
50 Kanchana 40 40-49 F 5 Sepsis N Y 0.60 4.00 1.80 133.00 1.90 A+/PUS+ Non Yes No IR acute F Infection No Exp 
51 Senthil 26 <30 M 2 F.hepatitis N N 1.20 2.40 0.00 120.00 1.30 Nor Non Yes Yes IR acute I Shock No Exp 
52 Mani 52 50-59 M 7 CuSo4 N N 1.60 1.90 1.10 86.00 0.80 HB+ Non No No PR acute I Toxin No Dis 
53 Salwarbe 75 >60 F 7 Sepsis N Y 2.10 5.10 0.00 104.00 2.10 A+/PUS+ Non No Yes IR A/C F Infection No Exp 
54 Sellammal 65 >60 F 2 Sepsis N Y 1.90 2.40 0.00 80.00 0.70 A+/PUS+ Non Yes Yes PR A/C F Infection No Exp 
55 Kathuri 65 >60 F 10 Sepsis N Y 4.40 13.90 3.50 107.00 1.90 A+ OLI Yes No IR A/C F Infection HD Exp 
56 Periyanna 19 <30 M 5 ADD N N 2.40 2.40 1.60 22.00 0.70 Nor Non Yes No PR acute I Shock No Dis 
57 Srinivasan 50 50-59 M 4 ADD N N 3.20 3.20 0.80 62.00 0.80 Nor Non Yes No PR acute I Shock No Dis 
58 Devadas 48 40-49 M 8 Sepsis N N 2.90 3.70 1.80 72.00 1.50 Nor Non No No IR acute I Infection No Exp 
59 Sekar 48 40-49 M 4 DCLD N Y 6.50 6.80 0.00 90.00 1.50 Nor OLI Yes Yes IR A/C F Infection No Exp 
60 Mathu 38 30-39 M 4 DCLD N N 1.50 6.50 0.00 28.00 1.40 Nor OLI No Yes IR acute F HRS No Exp 
61 Rajendiran 53 50-59 M 3 DCLD N N 2.20 5.20 0.00 40.00 1.30 Nor OLI No No IR acute F HRS No Exp 
62 Vasanthi 50 50-59 F 6 Sepsis N Y 2.10 2.40 1.90 70.00 0.50 K+ Non Yes No PR A/C I Shock No Dis 
63 Durai 65 >60 M 2 Sepsis N N 4.80 5.80 0.00 80.00 1.80 PUS+ OLI Yes Yes IR A/C F Infection PD Exp 
64 Padmanaban 66 >60 M 3 DCLD N N 2.20 2.80 0.00 42.00 1.30 Nor OLI No Yes IR acute I Infection No Exp 
65 Prithivirajan 46 40-49 M 2 DCLD Y Y 3.50 3.80 0.00 60.00 1.30 Nor OLI Yes Yes IR A/C F Infection No Exp 
66 Perumal 54 50-59 M 2 DCLD N N 4.10 6.20 0.00 40.00 1.10 Nor OLI No No IR acute F HRS No Exp 
67 anandhan 55 50-59 M 3 DCLD N N 3.20 5.60 0.00 40.00 1.10 Nor OLI No No IR acute F HRS No Exp 
68 Jayasree 37 30-39 F 3 F.hepatitis N N 2.10 2.40 0.00 64.00 0.60 PUS+ Non Yes Yes PR acute I Shock No Exp 
69 Shakir 43 40-49 M 5 DCLD N N 2.20 3.40 1.80 28.00 1.01 PUS+ OLI Yes Yes IR acute I Infection No Exp 
70 Abdul kasab 62 >60 M 2 Sepsis N N 1.30 2.10 0.00 26.00 0.70 Nor Non Yes Yes PR acute I Infection No Exp 
71 Mari 42 40-49 F 2 Sepsis Y Y 2.60 3.20 0.00 46.00 1.10 A+/PUS+ OLI Yes Yes IR A/C I Infection PD Exp 
72 Senthil 20 <30 M 5 F.hepatitis N N 2.30 2.40 1.60 56.00 0.70 Nor Non Yes No PR acute I Shock No Dis 
73 Raja 30 30-39 M 3 Renal N N 4.50 6.00 2.80 30.00 1.10 RBC+ OLI No No IR acute F HUS HD Exp 
74 Subramani 73 >60 M 3 Sepsis Y Y 2.80 3.10 0.00 80.00 1.30 A+/PUS+ Non Yes Yes IR A/C I Infection No Exp 
75 Murugan 45 40-49 M 7 Sepsis N N 2.60 5.80 1.80 66.00 1.20 Nor OLI No No IR acute F Infection HD Exp 
76 dharmendiran 35 30-39 M 4 CNS Y N 1.50 2.80 0.00 58.00 0.90 Nor Non Yes No PR acute I Shock No Exp 
77 Mohan 47 40-49 M 6 Renal N N 3.20 5.80 1.90 30.00 1.10 RBC+ OLI No No IR acute F HUS HD Exp 
78 Ganesan 28 <30 M 3 CVD N N 1.70 2.80 0.00 28.00 0.90 Nor OLI Yes Yes PR acute I Shock No Exp 
79 Ramamurthy 70 >60 M 5 ADD Y Y 3.70 4.20 2.20 70.00 0.80 Nor Non Yes No PR A/C F Shock No Dis 
80 Anwar basha 60 >60 M 3 F.hepatitis N N 3.20 6.80 0.00 30.00 1.20 Nor OLI No No IR A/C F HRS PD Exp 
81 Selvendiran 52 50-59 M 3 CVD Y Y 1.80 2.80 0.00 30.00 0.90 Nor OLI Yes Yes PR A/C I Shock No Exp 
82 Ravi 45 40-49 M 4 Sepsis Y Y 2.10 3.40 0.00 70.00 1.30 A+ Non Yes Yes IR A/C I Infection No Exp 
83 Bangaramma 35 30-39 F 5 Renal Y N 2.90 5.20 3.40 80.00 0.90 A+ OLI No No IR A/C F GN HD Exp 
  
 
 
 
 
